Author:
Lytton-Jean Abigail K. R.,Kauffman Kevin J.,Kaczmarek James C.,Langer Robert
Publisher
Springer International Publishing
Reference142 articles.
1. Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63(3):136–151
2. Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278–287
3. Vanneman M, Dranoff G (2012) Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12(4):237–251
4. Lipsky MS, Sharp LK (2001) From idea to market: the drug approval process. J Am Board Fam Med 14(5):362–367
5. Eifler AC, Thaxton CS (2011) Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. In: Hurst SJ (ed) Methods in molecular biology (Clifton NJ), vol 726. pp 325–38
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献